dementia program (Verge Genomics)

N/A

Report date: 2025/01/26 18:47:19
NME

Base Information

Drug Namedementia program (Verge Genomics)
Drug Alias Nameneurodegenerative disorder therapy (Verge Genomics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsSchizophreniaFrontotemporal DementiaDementia +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVerge Genomics Inc
China Registration ClassN/A

Develop Information

Active CompaniesVerge Genomics Inc
Inactive CompaniesN/A
Active IndicationsDementiaLewy Body Disease
Inactive IndicationsSchizophreniaFrontotemporal DementiaSupranuclear Palsy, Progressive

Other Information

ATC CodeN/A
Related LinksN/A